MET Exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
Somatic MET exon 14 skipping mutations (MET ex14) are targetable driver mutations for non-small cell lung cancer (NSCLC), responsive to MET inhibitors. Objective: This study seeks to further characterize the clinicopathologic features and mutational profile of MET ex14 variant NSCLC. Design: Retrosp...
Saved in:
Main Authors: | Lisi Yuan (Author), Harshita Mehrotra (Author), Xin He (Author), David Bosler (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-small-cell lung cancer: how to manage MET exon 14 skipping mutant disease
by: Juan Bautista Blaquier, et al.
Published: (2022) -
Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non-small cell lung cancer patients in resource constrained community hospitals
by: Anurag Mehta, et al.
Published: (2021) -
A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
by: Yan Chen, et al.
Published: (2022) -
Non-small Cell Lung Cancer with Concomitant , , and Mutation: Clinicopathologic Features of 12 Cases
by: Taebum Lee, et al.
Published: (2016) -
MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
by: Ji Ruan
Published: (2021)